+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Japanese Encephalitis Vaccines Market 2019-2023 - Product Image

Global Japanese Encephalitis Vaccines Market 2019-2023

  • ID: 4792909
  • Report
  • June 2019
  • Region: Global, Japan
  • 131 pages
  • TechNavio
UP TO OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE.
  • MORE
Global Japanese Encephalitis Vaccines Market: About this market

Japanese encephalitis is an inflammation in the brain, which is usually asymptomatic and is caused by a mosquito-borne flavivirus. This Japanese encephalitis vaccines market analysis considers sales from different type, including inactivated vaccines, recombinant vaccines, and live attenuated vaccines. Our analysis also considers the sales of Japanese encephalitis vaccines in Asia, Europe, North America, and ROW. In 2018, the inactivated vaccines segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing number of choices and wide treatment options of the segment will play a significant role in the inactivated vaccines segment to maintain its market position. Also, our global Japanese encephalitis vaccines market report looks at factors such as the inclusion in national immunization plan, strategic alliances, and a growing number of awareness campaigns. However, demand-supply imbalance, geographic concentration, and weak pipeline may hamper the growth of the Japanese encephalitis vaccines industry over the forecast period.

Global Japanese Encephalitis Vaccines market: Overview

Inclusion in national immunization plan

National immunization plans to prevent the high risk of Japanese encephalitis involves mass vaccinations. This plan results in an increased procurement of vaccination doses. The inclusion of vaccination against Japanese encephalitis in national immunization plans will lead to the expansion of the global Japanese encephalitis vaccines market at a CAGR of almost 9% during the forecast period.

Strong investments from BRICS in research

With the growing incidence of Japanese encephalitis, BRICS is developing vaccines against the indication. Pharmaceutical companies are supporting the development of these vaccines by investing in research and developmental activities. The presence of strong manufacturing facilities in BRICS countries is expected to have a positive impact on the overall market growth.

Competitive Landscape

With the presence of a few major players, the global Japanese encephalitis vaccines market is concentrated. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Japanese encephalitis vaccines manufacturers, that include Bharat Biotech Ltd., Biological E. Ltd., Green Cross Corp., Sanofi, and Valneva SE.

Also, the Japanese encephalitis vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06:  MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Inactivated vaccines - Market size and forecast 2018-2023
  • Recombinant vaccines - Market size and forecast 2018-2023
  • Live attenuated vaccines - Market size and forecast 2018-2023
  • Market opportunity by type
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • North America - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Novel vaccine technology
  • Strong investments from BRICS in research
  • Growing inbound travel to Asia
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Product overview
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Type - Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Inactivated vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Inactivated vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 22: Recombinant vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Recombinant vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 24: Live attenuated vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Live attenuated vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Asia
Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in ROW
Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Europe
Exhibit 39: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: North America - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in North America
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Bharat Biotech Ltd. - Vendor overview
Exhibit 51: Bharat Biotech Ltd. - Business segments
Exhibit 52: Bharat Biotech Ltd. - Organizational developments
Exhibit 53: Bharat Biotech Ltd. - Key offerings
Exhibit 54: Bharat Biotech Ltd. - Key customers
Exhibit 55: Biological E. Ltd. - Vendor overview
Exhibit 56: Biological E. Ltd. - Business segments
Exhibit 57: Biological E. Ltd. - Organizational developments
Exhibit 58: Biological E. Ltd. - Key offerings
Exhibit 59: Biological E. Ltd. - Key customers
Exhibit 60: Green Cross Corp. - Vendor overview
Exhibit 61: Green Cross Corp. - Business segments
Exhibit 62: Green Cross Corp. - Organizational developments
Exhibit 63: Green Cross Corp. - Geographic focus
Exhibit 64: Green Cross Corp. - Segment focus
Exhibit 65: Green Cross Corp. - Key offerings
Exhibit 66: Green Cross Corp. - Key customers
Exhibit 67: Sanofi - Vendor overview
Exhibit 68: Sanofi - Business segments
Exhibit 69: Sanofi - Organizational developments
Exhibit 70: Sanofi - Geographic focus
Exhibit 71: Sanofi - Segment focus
Exhibit 72: Sanofi - Key offerings
Exhibit 73: Sanofi - Key customers
Exhibit 74: Valneva SE - Vendor overview
Exhibit 75: Valneva SE - Business segments
Exhibit 76: Valneva SE - Organizational developments
Exhibit 77: Valneva SE - Geographic focus
Exhibit 78: Valneva SE - Segment focus
Exhibit 79: Valneva SE - Key offerings
Exhibit 80: Valneva SE - Key customers
Exhibit 81: Validation techniques employed for market sizing
Exhibit 82: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE.
  • MORE
The following companies are recognised as the key players in the global Japanese encephalitis vaccines market: Bharat Biotech Ltd., Biological E. Ltd., Green Cross Corp., Sanofi, and Valneva SE.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the strong investments from BRICS in research.”

According to the report, one of the major drivers for this market is the inclusion of vaccination against Japanese encephalitis in national immunization plans.

Further, the report states that one of the major factors hindering the growth of this market is the demand-supply imbalance.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Bharat Biotech Ltd.
  • Biological E. Ltd.
  • Green Cross Corp.
  • Sanofi
  • Valneva SE.
Note: Product cover images may vary from those shown
Adroll
adroll